MM-SZ01 Study: A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Study Which Compared Polyethylene Glycol Liposomal Doxorubicin Versus Doxorubicin Combined with Bortezomib and Dexamethasone (PDD regimen vs PAD regimen) in the Treatment of Newly Diagnosed Multiple Myeloma in China

Autor: Qingqing Wang, Depei Wu, Chengcheng Fu, Shuang Yan, ChengHao Jin, Xuzhang Lu, Tao Chen, Fei Li, Zhongjun Xia, Bingzhong Li
Rok vydání: 2022
Předmět:
Zdroj: Blood. 140:12614-12615
ISSN: 1528-0020
0006-4971
DOI: 10.1182/blood-2022-159065
Databáze: OpenAIRE